Details for 2021217086

Up to date per 02.04.2026

Actions

Title / Product Name

INTERLEUKIN-21-MUTEINE UND VERFAHREN ZUR BEHANDLUNG

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2021217086

EP Publication Number

4029877

E-Number

1650482

Language

PCT Number

Publication Date

20.07.2022 A

17.01.2024 B1

Registration Date

17.01.2024

AT Publication Date

15.02.2024

Application Date

03.08.2018

Registration Number

Priorities

03.08.2017

201762540692 P

12.01.2018

201862616733 P

IPC

C07K 14/54 20060101AFI20220614BHEP

Maximum Duration of Protection

03.08.2038

Owner

Amgen Inc.One Amgen Center Drive Thousand Oaks, CA 91320-1799US

Representative

No representatives present

Inventor

ALI, Khaled, M.K.Z. Thousand Oaks, CA 91320US

AGRAWAL, Neeraj, Jagdish Thousand Oaks, CA 91320US

KANNAN, Gunasekaran Thousand Oaks, CA 91320US

FOLTZ, Ian Thousand Oaks, CA 91320US

WANG, Zhulun Thousand Oaks, CA 91320US

BATES, Daren Thousand Oaks, CA 91320US

MOCK, Marissa Thousand Oaks, CA 91320US

TAKENAKA, Shunseke Thousand Oaks, CA 91320US